125 related articles for article (PubMed ID: 24518383)
21. Necrobiotic xanthogranuloma without a monoclonal gammopathy.
Seastrom S; Bookout A; Hogan DJ
Cutis; 2014 Dec; 94(6):293-6. PubMed ID: 25566570
[TBL] [Abstract][Full Text] [Related]
22. Hepatobiliary and Pancreatic: Hepatic necrobiotic xanthogranuloma.
Nguyen BD
J Gastroenterol Hepatol; 2017 Oct; 32(10):1667. PubMed ID: 28948701
[No Abstract] [Full Text] [Related]
23. Necrobiotic xanthogranuloma: response to dapsone.
Wei YH; Cheng JJ; Wu YH; Liu CY; Hung CJ; Hsu JD; Hsiao YP
Dermatol Ther; 2015; 28(1):7-9. PubMed ID: 25314033
[No Abstract] [Full Text] [Related]
24. Necrobiotic xanthogranuloma.
Jaén-Águila F; Vargas-Hitos JA; Jiménez-Alonso J
QJM; 2014 Oct; 107(10):859. PubMed ID: 24659748
[No Abstract] [Full Text] [Related]
25. Complete response to thalidomide and dexamethasone in a patient with necrobiotic xanthogranuloma associated with monoclonal gammopathy: a case report and review of the literature.
Efebera Y; Blanchard E; Allam C; Han A; Lee S; Munshi N
Clin Lymphoma Myeloma Leuk; 2011 Jun; 11(3):298-302. PubMed ID: 21658660
[TBL] [Abstract][Full Text] [Related]
26. Letter: Necrobiotic xanthogranuloma of extremities in an elderly patient successfully treated with low-dose prednisolone.
Kawakami Y; Yamamoto T
Dermatol Online J; 2011 Jun; 17(6):13. PubMed ID: 21696693
[TBL] [Abstract][Full Text] [Related]
27. Treatment of necrobiotic xanthogranuloma - a systematic review.
Miguel D; Lukacs J; Illing T; Elsner P
J Eur Acad Dermatol Venereol; 2017 Feb; 31(2):221-235. PubMed ID: 27436448
[TBL] [Abstract][Full Text] [Related]
28. Successful multimodality treatment of recalcitrant necrobiotic xanthogranuloma using electron beam radiation and intravenous immunoglobulin.
Nambudiri VE; McLaughlin C; Lo TC; Zembowicz A; Moschella S
Clin Exp Dermatol; 2016 Mar; 41(2):179-82. PubMed ID: 26206141
[TBL] [Abstract][Full Text] [Related]
29. Necrobiotic xanthogranuloma with predominant periorbital involvement.
Oestreicher J; Dookeran R; Nijhawan N; Kolin A
Ophthalmic Plast Reconstr Surg; 2010; 26(6):473-5. PubMed ID: 21099384
[TBL] [Abstract][Full Text] [Related]
30. Distinctive Pattern of Adipophilin Expression in Necrobiotic Xanthogranuloma.
Saggini A; Cota C; Cerroni L
Am J Dermatopathol; 2016 Jun; 38(6):468-70. PubMed ID: 26981735
[No Abstract] [Full Text] [Related]
31. Slowly growing yellow nodules: challenge. Necrobiotic xanthogranuloma.
Gergen N; Biebl K; Berg BC; Suwattee P
Am J Dermatopathol; 2011 Feb; 33(1):92-3, 103-4. PubMed ID: 20644464
[No Abstract] [Full Text] [Related]
32. Necrobiotic xanthogranuloma with multiple myeloma.
Bhari N; Chiramel MJ; Vedi KK; Nath D; Sandip S; Kumar R; Kumar L; Sharma VK; Sethuraman G
Clin Exp Dermatol; 2015 Oct; 40(7):811-4. PubMed ID: 25809408
[No Abstract] [Full Text] [Related]
33. Nonnecrobiotic necrobiotic xanthogranuloma as an initial manifestation of paraproteinemia and small lymphocytic lymphoma in a patient with Sjögren syndrome.
Naghashpour M; Setoodeh R; Moscinski L; Bergier G; McCardle T; Glass F; Sokol L
Am J Dermatopathol; 2011 Dec; 33(8):855-7. PubMed ID: 22042261
[TBL] [Abstract][Full Text] [Related]
34. Intravenous immunoglobulin for treatment of necrobiotic xanthogranuloma.
Goyal A; O'Leary D; Vercellotti G; Miller D; McGlave P
Dermatol Ther; 2019 Jan; 32(1):e12744. PubMed ID: 30221815
[No Abstract] [Full Text] [Related]
35. Necrobiotic xanthogranuloma with giant cell hepatitis, successfully treated with intravenous immunoglobulins.
Pedrosa AF; Ferreira O; Calistru A; Mota A; Baudrier T; Sarmento JA; Bettencourt H; Azevedo F
Dermatol Ther; 2015; 28(2):68-70. PubMed ID: 25650024
[No Abstract] [Full Text] [Related]
36. Transfer factor for the treatment of necrobiotic xanthogranuloma.
Tang Z; Ruan J; Cai S
Dermatol Ther; 2022 Dec; 35(12):e15894. PubMed ID: 36196500
[No Abstract] [Full Text] [Related]
37. Efficacy of Topical Use Crisaborole 2% Ointment for Treatment of Necrobiotic Xanthogranuloma Associated With Multiple Myeloma.
Henning C; Meyers S; Swift R; Eades B; Bussell L; Spektor TM; Berenson JR
Clin Lymphoma Myeloma Leuk; 2020 Aug; 20(8):e492-e495. PubMed ID: 32389673
[No Abstract] [Full Text] [Related]
38. Systemic therapy of necrobiotic xanthogranuloma: a systematic review.
Steinhelfer L; Kühnel T; Jägle H; Mayer S; Karrer S; Haubner F; Schreml S
Orphanet J Rare Dis; 2022 Mar; 17(1):132. PubMed ID: 35331271
[TBL] [Abstract][Full Text] [Related]
39. Orbital necrobiotic xanthogranuloma associated with systemic IgG4 disease.
Singh K; Rajan KD; Eberhart C
Ocul Immunol Inflamm; 2010 Oct; 18(5):373-8. PubMed ID: 20716008
[TBL] [Abstract][Full Text] [Related]
40. Necrobiotic xanthogranuloma.
Efebera Y
Clin Adv Hematol Oncol; 2011 Sep; 9(9):700-1. PubMed ID: 22402516
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
